Immediate Impact
8 from Science/Nature 54 standout
Citing Papers
Multidrug-resistant Gram-negative bacterial infections
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Christopher Lucasti being referenced
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
2016
Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Lucasti | 133 | 524 | 294 | 500 | 35 | 1.1k | |
| Ómar Vesga | 108 | 523 | 427 | 350 | 33 | 1.3k | |
| Paul R. Ingram | 66 | 349 | 386 | 368 | 61 | 1.4k | |
| L. Leibovici | 108 | 222 | 176 | 265 | 38 | 1.2k | |
| Enrico Tagliaferri | 59 | 339 | 260 | 584 | 35 | 1.1k | |
| Elodie von Dach | 75 | 350 | 164 | 201 | 35 | 1.0k | |
| Matthew A. Wikler | 391 | 328 | 263 | 306 | 21 | 1.4k | |
| Cynthia L. Fowler | 37 | 606 | 256 | 350 | 21 | 1.1k | |
| Sorabh Dhar | 79 | 232 | 216 | 430 | 55 | 894 | |
| Abrar K. Thabit | 238 | 303 | 300 | 316 | 87 | 1.1k | |
| Lance R. Peterson | 97 | 186 | 633 | 224 | 30 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...